Self-reported health of Australian Defence Force personnel after use of anti-malarial drugs on deployment

Abstract

The Departments of Defence and Veterans’ Affairs commissioned UQ School of Public Health to use data from health studies of the ADF deployments to East Timor and Bougainville to investigate anti-malarial drug use and health outcomes.\ua0This report presents the results of a descriptive analysis of self-reported anti-malarial drug use on deployment and self-reported health.Personnel who used the drug mefloquine reported more symptoms of psychological distress than those who used other anti-malarial drugs. However, the average differences observed were below the threshold of clinical significance and based on a small sample size in the mefloquine group.\ua0Fifty-seven participants (1.6% of the sample)\ua0mentioned the use of anti-malarial drugs as a concern in response to open-ended survey questions

    Similar works